Allergan2525 Dupont Dr Irvine Ca 92612 Pma Numberp050047 Supplement Numbers085 Date Received04 01 2022 Decision Date04 28 2022 Product Code Lmh Advisory Committee General Plastic Surgery Supplement Type30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Allergan2525 Dupont Dr Irvine Ca 92612 Pma Numberp050047 Supplement Numbers085 Date Received04 01 2022 Decision Date04 28 2022 Product Code Lmh Advisory Committee General Plastic Surgery Supplement Type30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Registration(s)

FDA Filings

Device
Company
DeviceDate
Allergan2525 Dupont Dr.irvine, CA 92612 PMA NumberP050047 Supplement NumberS085 Date Received04/01/2022 Decision Date04/28/2022 Product Code LMH  Advisory Committee General & Plastic Surgery Supplement Type30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No
Juvéderm Ultra, Ultra XC and Ultra Plus XC, Juvéderm Ultra XC2022-04-28

Related Finance Registrations

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.